This week's View discusses three recent trials: CLOSE, RESPECT, and REDUCE. All three compared the outcomes of patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke, and all three were published in the New England Journal of Medicine on September 14th.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Congenital Heart Disease and Pediatric Cardiology, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias

Keywords: Foramen Ovale, Patent, Anticoagulants, Arrhythmias, Cardiac, Pediatrics, Heart Defects, Congenital, EaglesEyeView

< Back to Listings